Correlation between Mutations in liaFSR of Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin Breakpoints
Open accessAbstract
Mutations in liaFSR , a three-component regulatory system controlling cell-envelope stress response, were recently linked with the emergence of daptomycin (DAP) resistance in enterococci. Our previous work showed that a liaF mutation increased the DAP MIC of a vancomycin-resistant Enterococcus faecalis strain from 1 to 3 μg/ml (the DAP breakpoint is 4 μg/ml), suggesting that mutations in the liaFSR system could be a pivotal initial event in the development of DAP resistance. With the hypothesis that clinical enterococcal isolates with DAP MICs between 3 and 4 μg/ml might harbor mutations in liaFSR , we studied 38 Enterococcus faecium bloodstream isolates, of which 8 had DAP MICs between 3 and 4 μg/ml by Etest in Mueller-Hinton agar. Interestingly, 6 of these 8 isolates had predicted amino acid changes in the LiaFSR system. Moreover, we previously showed that among 6 DAP-resistant E. faecium isolates (MICs of >4 μg/ml), 5 had mutations in liaFSR . In contrast, none of 16 E. faecium isolates with a DAP MIC of ≤2 μg/ml harbored mutations in this system ( P < 0.0001). All but one isolate with liaFSR changes exhibited DAP MICs of ≥16 μg/ml by Etest using brain heart infusion agar (BHIA), a medium that better supports enterococcal growth. Our findings provide a strong association between DAP MICs within the upper susceptibility range and mutations in the liaFSR system. Concomitant susceptibility testing on BHIA may be useful for identifying these E. faecium first-step mutants. Our results also suggest that the current DAP breakpoint for E. faecium may need to be reevaluated.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The majority (75%) of DAP-susceptible E. faecium isolates recovered from bacteremic patients whose MIC was in the higher range of susceptibility (between 3 and 4 μg/mL) harbored mutations in LiaFSR.
“Furthermore, the majority (75%) of DAP-susceptible E. faecium isolates recovered from bacteremic patients whose MIC was in the higher range of susceptibility (i.e. between 3 and 4 μg/mL) harbored mutations in LiaFSR.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [91]
None of the E. faecium isolates with DAP MIC ≤ 2 μg/mL exhibited changes in LiaFSR.
“Conversely, none of the isolates of the same collection with DAP MIC ≤ 2 μg/mL exhibited changes in this system (91).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [91]
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572 · see citing works
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875 · see citing works
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,203 · see citing works
Self-citationClinical and Laboratory Standards Institute
Gressner, A. M., & Arndt, T. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,092 · see citing works
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D. N., Rice, L. B., Scheld, M., Spellberg, B. J., & Bartlett, J. (2008) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,978 · see citing works
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724 · see citing works
Dutka‐Malen, S., Evers, S., & Courvalin, P. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.1.24-27.1995 · Cited by 1,406 · see citing works
Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge
Arias, C. A., & Murray, B. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0804651 · Cited by 1,035 · see citing works
Self-citationIn vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis
Sahm, D. F., Kissinger, J. C., Gilmore, M. S., Murray, P. R., Mulder, R., Solliday, J., & Clarke, B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1588 · Cited by 497 · see citing works
Murray, B. E., Singh, K. V., Heath, J. D., Sharma, B. R., & Weinstock, G. M. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.9.2059-2063.1990 · Cited by 487 · see citing works
Self-citationCell envelope stress response in Gram-positive bacteria
Jordan, S., Hutchings, M. I., & Mascher, T. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2007.00091.x · Cited by 387 · see citing works
Management of multidrug-resistant enterococcal infections
Arias, C. A., Contreras, G., & Murray, B. E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03214.x · Cited by 384 · see citing works
Self-citationGenetic Basis for In Vivo Daptomycin Resistance in Enterococci
Arias, C. A., Panesso, D., McGrath, D. M., Qin, X., Mojica, M. F., Miller, C., Diaz, L., Tran, T. T., Rincon, S., Barbu, E. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011138 · Cited by 377 · see citing works
Self-citationCell wall stress responses in Bacillus subtilis: the regulatory network of the bacitracin stimulon
Mascher, T., Margulis, N. G., Wang, T., Ye, R. W., & Helmann, J. D. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03786.x · Cited by 308 · see citing works
Peleg, A. Y., Miyakis, S., Ward, D. V., Earl, A. M., Rubio, A., Cameron, D. R., Pillai, S. K., Moellering, R. C., & Eliopoulos, G. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028316 · Cited by 237 · see citing works
Emergence of Daptomycin Resistance in Enterococcus faecium during Daptomycin Therapy
Sabol, K., PATTERSON, J. E., Lewis, J. S., Owens, A. D., Cadena, J., & Jorgensen, J. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1664-1665.2005 · Cited by 209 · see citing works
Murray, B. E., Singh, K. V., Ross, R. P., Heath, J. D., Dunny, G. M., & Weinstock, G. M. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.16.5216-5223.1993 · Cited by 203 · see citing works
Self-citationGenetic Basis for Daptomycin Resistance in Enterococci
Palmer, K. L., Daniel, A., Hardy, C., Silverman, J. A., & Gilmore, M. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00207-11 · Cited by 189 · see citing works
Gardete, S., Wu, S. W., Gill, S. R., & Tomasz, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00356-06 · Cited by 189 · see citing works
Munoz-Price, L. S., Lolans, K., & Quinn, J. P. (2005) · Clinical Infectious Diseases · doi:10.1086/432121 · Cited by 157 · see citing works
Galloway-Peña, J., Roh, J. H., Latorre, M., Qin, X., & Murray, B. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030187 · Cited by 148 · see citing works
Self-citationThe LiaFSR System Regulates the Cell Envelope Stress Response inStreptococcus mutans
Suntharalingam, P., Senadheera, M. D., Mair, R. W., Levesque, C. M., & Cvitkovitch, D. G. (2009) · Journal of Bacteriology · doi:10.1128/jb.01563-08 · Cited by 141 · see citing works
FUCHS, P. C., Barry, A. L., & Brown, S. D. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00164-4 · Cited by 122 · see citing works
Boyle‐Vavra, S., Yin, S., & Daum, R. S. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00384.x · Cited by 102 · see citing works
Daptomycin Dose-Effect Relationship against Resistant Gram-Positive Organisms
Cha, R., Grucz, R. G., & Rybak, M. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1598-1603.2003 · Cited by 95 · see citing works
A potential role for daptomycin in enterococcal infections: what is the evidence?
Cantón, R., Ruíz-Garbajosa, P., Chaves, R. L., & Johnson, A. P. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq087 · Cited by 93 · see citing works
Arias, C. A., Torres, H. A., Singh, K. V., Panesso, D., Moore, J. E., Wanger, A. R., & Murray, B. E. (2007) · Clinical Infectious Diseases · doi:10.1086/522656 · Cited by 84 · see citing works
Self-citationArias, C. A., Panesso, D., Singh, K. V., Rice, L. B., & Murray, B. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00242-09 · Cited by 79 · see citing works
Self-citationClinical experience with daptomycin in Europe: the first 2.5 years
González-Ruiz, A., Beiras-Fernández, A., Lehmkuhl, H., Seaton, R. A., Loeffler, J., & Chaves, R. L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq528 · Cited by 79 · see citing works
Eldholm, V., Gutt, B., Johnsborg, O., Brückner, R., Maurer, P., Hakenbeck, R., Mascher, T., & Håvarstein, L. S. (2010) · Journal of Bacteriology · doi:10.1128/jb.01489-09 · Cited by 63 · see citing works
Kohner, P. C., Patel, R., Uhl, J. R., Garin, K. M., Hopkins, M. K., Wegener, L. T., & Cockerill, F. R. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.12.3258-3263.1997 · Cited by 53 · see citing works
Jorgensen, J. H., Crawford, S. A., Kelly, C. C., & PATTERSON, J. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3760-3763.2003 · Cited by 52 · see citing works
FUCHS, P. C. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.4.557 · Cited by 46 · see citing works
Chambers, H. F., Basuino, L., Diep, B. A., Steenbergen, J., Zhang, S., Tattevin, P., & Alder, J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01307-08 · Cited by 42 · see citing works
De Novo Daptomycin Nonsusceptibility in a Clinical Isolate
Lesho, E. P., Wortmann, G. W., Craft, D. W., & Moran, K. A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.673.2006 · Cited by 35 · see citing works
Schwartz, B. S., Ngo, P. D., & Guglielmo, B. J. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1k548 · Cited by 33 · see citing works
Koeth, L. M., & DiFranco, J. M. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0996-x · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782 · see citing works
Self-citationMechanisms of antibiotic resistance in enterococci
Miller, W. R., Munita, J. M., & Arias, C. A. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.956092 · Cited by 772 · see citing works
Self-citationBacterial stress responses as determinants of antimicrobial resistance
Poole, K. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks196 · Cited by 515 · see citing works
Mechanisms of antibiotic resistance
Munita, J. M., & Arias, C. A. (2016) · Virulence Mechanisms of Bacterial Pathogens · doi:10.1128/9781555819286.ch17 · Cited by 421 · see citing works
Self-citationGlobal Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?
Prieto, A. M. G., van Schaik, W., Rogers, M. R. C., Coque, T. M., Baquero, F., Corander, J., & Willems, R. J. L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00788 · Cited by 386 · see citing works
A Current Perspective on Daptomycin for the Clinical Microbiologist
Humphries, R. M., Pollett, S., & Sakoulas, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-13 · Cited by 239 · see citing works
Mechanisms of drug resistance: daptomycin resistance
Tran, T. T., Munita, J. M., & Arias, C. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12948 · Cited by 236 · see citing works
Self-citationMechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and EnterococciPreprint
Miller, W. R., Bayer, A. S., & Arias, C. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026997 · Cited by 229 · see citing works
Self-citationTran, T. T., Panesso, D., Mishra, N. N., Mileykovskaya, E., Guan, Z., Munita, J. M., Reyes, J., Diaz, L., Weinstock, G. M., Murray, B. E., et al. (2013) · mBio · doi:10.1128/mbio.00281-13 · Cited by 192 · see citing works
Self-citationResistance in Vancomycin-Resistant Enterococci
Miller, W. R., Murray, B. E., Rice, L. B., & Arias, C. A. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.08.004 · Cited by 176 · see citing works
Self-citationDoi, Y., Bonomo, R. A., Hooper, D. C., Kaye, K. S., Johnson, J. R., Clancy, C. J., Thaden, J. T., Stryjewski, M. E., & van Duin, D. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw829 · Cited by 151 · see citing works
Vancomycin Resistance in Enterococcus and Staphylococcus aureus
Li, G., Walker, M. J., & Oliveira, D. M. P. D. (2022) · Microorganisms · doi:10.3390/microorganisms11010024 · Cited by 151 · see citing works
Whole-Genome Analyses of Enterococcus faecium Isolates with Diverse Daptomycin MICs
Díaz, L., Tran, T. T., Munita, J. M., Miller, W. R., Rincón, S., Carvajal, L. P., Wollam, A., Reyes, J., Panesso, D., Rojas, N. L., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02686-14 · Cited by 138 · see citing works
Self-citationSmith, J. R., Barber, K. E., Raut, A., Aboutaleb, M., Sakoulas, G., & Rybak, M. J. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv007 · Cited by 136 · see citing works
Evolving Resistance Among Gram-positive Pathogens
Munita, J. M., Bayer, A. S., & Arias, C. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ523 · Cited by 134 · see citing works
Self-citationThe Ribosomal S10 Protein Is a General Target for Decreased Tigecycline Susceptibility
Beabout, K., Hammerstrom, T. G., Perez, A. M., Magalhães, B. D. F., Prater, A. G., Clements, T. P., Arias, C. A., Saxer, G., & Shamoo, Y. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00547-15 · Cited by 129 · see citing works
Self-citationTran, T. T., Panesso, D., Gao, H., Roh, J. H., Munita, J. M., Reyes, J., Diaz, L., Lobos, E. A., Shamoo, Y., Mishra, N. N., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01454-12 · Cited by 125 · see citing works
Self-citationVancomycin-Resistant Enterococci
Miller, W. R., Murray, B. E., Rice, L. B., & Arias, C. A. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.006 · Cited by 124 · see citing works
Self-citationGray, D. A., & Wenzel, M. (2020) · Antibiotics · doi:10.3390/antibiotics9010017 · Cited by 107 · see citing works
Shukla, B. S., Shelburne, S. A., Reyes, K., Kamboj, M., Lewis, J. D., Rincón, S., Reyes, J., Carvajal, L. P., Panesso, D., Sifri, C. D., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw173 · Cited by 107 · see citing works
Self-citationAdaptation of Enterococcus faecalis to Daptomycin Reveals an Ordered Progression to Resistance
Miller, C. A., Kong, J., Tran, T. T., Arias, C. A., Saxer, G., & Shamoo, Y. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01473-13 · Cited by 103 · see citing works
Self-citationAntibiotic resistance inEnterococcus faeciumclinical isolates
Cattoir, V., & Giárd, J.-C. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.870886 · Cited by 105 · see citing works
Chuang, Y., Lin, H., Chen, P., Lin, C., Wang, J., Chen, Y., & Chang, S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix024 · Cited by 100 · see citing works
Reyes, J., Panesso, D., Tran, T. T., Mishra, N. N., Cruz, M. R., Munita, J. M., Singh, K. V., Yeaman, M. R., Murray, B. E., Shamoo, Y., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu602 · Cited by 94 · see citing works
Self-citationWhat's New from the CLSI Subcommittee on Antimicrobial Susceptibility Testing M100, 29th Edition
Abbey, T. C., & Deák, E. (2019) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2019.11.002 · Cited by 95 · see citing works
Sakoulas, G., Rose, W., Nonejuie, P., Olson, J., Pogliano, J., Humphries, R., & Nizet, V. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02274-13 · Cited by 94 · see citing works
Dadashi, M., Sharifian, P., Bostanshirin, N., Hajikhani, B., Bostanghadiri, N., Khosravi-Dehaghi, N., van Belkum, A., & Darban‐Sarokhalil, D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.720647 · Cited by 90 · see citing works
Yim, J., Smith, J. R., & Rybak, M. J. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1922 · Cited by 82 · see citing works
Structure–Activity Relationships of Daptomycin Lipopeptides
Karas, J. A., Carter, G. P., Howden, B. P., Turner, A. M., Paulin, O. K. A., Swarbrick, J., Baker, M. A., Li, J., & Velkov, T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00780 · Cited by 81 · see citing works
Mechanisms of antimicrobial resistance among hospital-associated pathogens
Khan, A., Miller, W. R., & Arias, C. A. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1456919 · Cited by 77 · see citing works
Self-citationAntimicrobial Susceptibility Testing for Enterococci
Khan, A., Miller, W. R., Axell‐House, D. B., Munita, J. M., & Arias, C. A. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.00843-21 · Cited by 80 · see citing works
Self-citationMunita, J. M., Tran, T. T., Diaz, L., Panesso, D., Reyes, J., Murray, B. E., & Arias, C. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00021-13 · Cited by 70 · see citing works
Self-citationMunita, J. M., Mishra, N. N., Alvarez, D., Tran, T. T., Diaz, L., Panesso, D., Reyes, J., Murray, B. E., Adachi, J. A., Bayer, A. S., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu642 · Cited by 70 · see citing works
Self-citationRenzoni, A., Kelley, W. L., Rosato, R. R., Martínez, M. P. S., Roch, M., Fatouraei, M., Haeusser, D. P., Margolin, W., Fenn, S. J., Turner, R. D., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01634-16 · Cited by 64 · see citing works
Ríos, R., Reyes, J., Carvajal, L. P., Rincón, S., Panesso, D., Echeverri, A. M., Dinh, A. Q., Kolokotronis, S., Narechania, A., Tran, T. T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62371-7 · Cited by 62 · see citing works
Self-citationDoernberg, S. B., Lodise, T. P., Thaden, J. T., Munita, J. M., Cosgrove, S. E., Arias, C. A., Boucher, H. W., Corey, G. R., Lowy, F. D., Murray, B. E., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw828 · Cited by 62 · see citing works
Self-citationAvery, L. M., Kuti, J. L., Weisser, M., Egli, A., Rybak, M. J., Zasowski, E. J., Arias, C. A., Contreras, G., Chong, P. P., Aitken, S. L., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy749 · Cited by 59 · see citing works
Self-citationSmith, J. R., Barber, K. E., Raut, A., & Rybak, M. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00053-15 · Cited by 57 · see citing works
Lellek, H., Franke, G. C., Ruckert, C., Wolters, M., Wolschke, C., Christner, M., Büttner, H., Alawi, M., Kröger, N., & Rohde, H. (2015) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2015.09.005 · Cited by 49 · see citing works
Kebriaei, R., Rice, S., Singh, K. V., Stamper, K. C., Dinh, A. Q., Ríos, R., Díaz, L., Murray, B. E., Munita, J. M., Tran, T. T., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00315-18 · Cited by 44 · see citing works
Self-citationThe Cell Wall Architecture of Enterococcus Faecium : From Resistance to Pathogenesis
Hendrickx, A. P. A., van Schaik, W., & Willems, R. J. L. (2013) · Future Microbiology · doi:10.2217/fmb.13.66 · Cited by 44 · see citing works
Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci
Munita, J. M., Murray, B. E., & Arias, C. A. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.08.002 · Cited by 43 · see citing works
Self-citationHindler, J. A., Wong‐Beringer, A., Charlton, C. L., Miller, S. A., Kelesidis, T., Carvalho, M., Sakoulas, G., Nonejuie, P., Pogliano, J. A., Nizet, V., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05077-14 · Cited by 43 · see citing works
McElvania, E., Thomas, B. S., Ewald, G. A., Lawrence, S. J., & Burnham, C. D. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2188-6 · Cited by 43 · see citing works
Panesso, D., Reyes, J., Gaston, E. P., Deal, M., Londoño, A., Nigo, M., Munita, J. M., Miller, W. R., Shamoo, Y. E., Tran, T. T., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01073-15 · Cited by 40 · see citing works
Self-citationCampeau, S. A., Schuetz, A. N., Kohner, P. C., Arias, C. A., Hemarajata, P., Bard, J. D., & Humphries, R. M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00745-18 · Cited by 42 · see citing works
Self-citationMiller, W. R., Tran, T. T., Díaz, L., Ríos, R., Khan, A., Reyes, J., Prater, A. G., Panesso, D., Shamoo, Y. E., & Arias, C. A. (2018) · Molecular Microbiology · doi:10.1111/mmi.14193 · Cited by 37 · see citing works
Self-citationClinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia
Moise, P. A., Sakoulas, G., McKinnell, J. A., Lamp, K. C., DePestel, D. D., Yoon, M., Reyes, K., & Zervos, M. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.04.008 · Cited by 40 · see citing works
Davlieva, M. G., Shi, Y., Leonard, P. G., Johnson, T. A., Zianni, M. R., Arias, C. A., Ladbury, J. E., & Shamoo, Y. E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv321 · Cited by 39 · see citing works
Self-citationWang, G., Yu, F., Lin, H. C., Murugesan, K., Huang, W., Hoss, A. G., Dhand, A., Lee, L. Y., Zhuge, J., Yin, C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209785 · Cited by 34 · see citing works
Chacko, K., Sullivan, M. J., Beckford, C., Altman, D. R., Ciferri, B., Pak, T. R., Sebra, R., Kasarskis, A., Hamula, C. L. A., & van Bakel, H. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02007-17 · Cited by 31 · see citing works
Jahanbakhsh, S., Singh, N. B., Yim, J., Kebriaei, R., Smith, J. R., Lev, K. L., Tran, T. T., Rose, W. E., Arias, C. A., & Rybak, M. J. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02074-19 · Cited by 32 · see citing works
Self-citationDavlieva, M. G., Tovar-Yanez, A., DeBruler, K., Leonard, P. G., Zianni, M. R., Arias, C. A., & Shamoo, Y. E. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.09.016 · Cited by 29 · see citing works
Self-citationChuang, Y., Lin, H., Yang, J. L., Lin, C. Y., Huang, S. H., Wang, J. T., Chen, Y., & Chang, S. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac164 · Cited by 28 · see citing works
Greene, M. H., Harris, B. D., Nesbitt, W. J., Watson, M. L., Wright, P. W., Talbot, T. R., & Nelson, G. E. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy185 · Cited by 27 · see citing works
Rincón, S., Panesso, D., Díaz, L., Carvajal, L. P., Reyes, J., Munita, J. M., & Arias, C. A. (2014) · Biomédica · doi:10.7705/biomedica.v34i0.2210 · Cited by 35 · see citing works
Self-citationSinel, C., Cosquer, T., Auzou, M., Goux, D., Giárd, J.-C., & Cattoir, V. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw229 · Cited by 26 · see citing works
Zeng, W., Feng, L., Qian, C., Chen, T., Wang, S., Zhang, Y., Zheng, X., Wang, L., Liu, S., Zhou, T., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.815600 · Cited by 24 · see citing works
Adams, H. M., Li, X., Mascio, C. T. M., Chesnel, L., & Palmer, K. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00526-15 · Cited by 25 · see citing works
Targeting cell membrane adaptation as a novel antimicrobial strategy
Tran, T. T., Miller, W. R., Shamoo, Y. E., & Arias, C. A. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.07.002 · Cited by 24 · see citing works
Self-citationLi, L., Higgs, C. K., Turner, A. M., Nong, Y., Gorrie, C. L., Sherry, N. L., Dyet, K. H., Seemann, T., Williamson, D. A., Stinear, T. P., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.749935 · Cited by 23 · see citing works
Kinnear, C. L., Patel, T. S., Young, C. L., Marshall, V. D., Newton, D. W., Read, A. F., & Woods, R. J. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01800-18 · Cited by 22 · see citing works
Echeverría-Esnal, D., Sorlí, L., Navarrete-Rouco, M. E., Prim, N., Barceló‐Vidal, J., Conde‐Estévez, D., Montero, M., Martín‐Ontiyuelo, C., Horcajada, J. P., & Grau, S. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2223977 · Cited by 22 · see citing works
Egli, A., Schmid, H., Kuenzli, E., Widmer, A. F., Battegay, M., Plagge, H., Frei, R., Achermann, R., & Weisser, M. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.10.003 · Cited by 20 · see citing works
Chong, P. P., van Duin, D., Bangdiwala, A. S., Ivanova, A., Miller, W. C., Weber, D. J., Gilligan, P. H., & Shea, T. C. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.09.011 · Cited by 20 · see citing works
Chilambi, G. S., Hinks, J., Matysik, A. S., Zhu, X., Choo, P. Y., Liu, X., Chan‐Park, M. B. E., Bazan, G. C., Kline, K. A., & Rice, S. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00155 · Cited by 18 · see citing works
Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children
Tamma, P. D., & Hsu, A. J. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000115 · Cited by 18 · see citing works
Udaondo, Z., Jenjaroenpun, P., Wongsurawat, T., Meyers, E., Anderson, C., Lopez, J., Mohan, M., Tytarenko, R. G., Walker, B. A., Ussery, D. W., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa180 · Cited by 17 · see citing works
Wang, G., Kamalakaran, S., Dhand, A., Huang, W., Ojaimi, C., Zhuge, J., Yee, L. L., Mayigowda, P., Surendraiah, P. K. M., Dimitrova, N., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02683-14 · Cited by 16 · see citing works
Carvalhaes, C. G., Sader, H. S., Flamm, R. K., Streit, J. M., & Mendes, R. E. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00175-20 · Cited by 16 · see citing works
Chilambi, G. S., Gao, I. H., Yoon, B. K., Park, S.-H., Kawakami, L. M., Ravikumar, V., Chan‐Park, M. B. E., Cho, N., Bazan, G. C., Kline, K. A., et al. (2018) · RSC Advances · doi:10.1039/c7ra11823f · Cited by 16 · see citing works
[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].
Rincón, S., Panesso, D., Díaz, L., Carvajal, L. P., Reyes, J., Munita, J. M., & Arias, C. A. (2014) · PubMed · doi:10.1590/s0120-41572014000500022 · Cited by 16 · see citing works
Self-citationBacterial Stress Responses as Determinants of Antimicrobial Resistance
Fruci, M., & Poole, K. (2016) · doi:10.1002/9781119004813.ch10 · Cited by 15 · see citing works
Cusumano, J. A., Khan, R., Shah, Z., Philogene, C., Harrichand, A., & Huang, V. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00621-22 · Cited by 14 · see citing works
Belley, A. C., Arhin, F. F., & Moeck, G. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01873-17 · Cited by 14 · see citing works
Treatment of Vancomycin-Resistant Enterococci: Focus on Daptomycin
Kohinke, R. M., & Pakyz, A. L. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0589-2 · Cited by 13 · see citing works
Wan, T., Yeo, H., Lee, T.-F., Huang, Y., Hsueh, P., & Chiu, H. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac414 · Cited by 13 · see citing works
Kaushik, S., Yadav, J., Das, S., Karthikeyan, D., Chug, R., Jyoti, A., Srivastava, V. K., Jain, A., Kumar, S., & Sharma, V. (2022) · Current Protein and Peptide Science · doi:10.2174/1389203723666220526155644 · Cited by 12 · see citing works
Cusumano, J. A., Daffinee, K. E., Ugalde‐Silva, P., Peti, W., Arthur, M., Desbonnet, C. R., Rice, L. B., LaPlante, K. L., & Garcia-Solache, M. A. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00871-22 · Cited by 12 · see citing works
Chuang, Y., Lin, H., Wang, J., Yang, J., Lin, C., Huang, S., Chen, Y., & Chang, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113710 · Cited by 11 · see citing works
Woods, R. J., Patel, T. S., Nagel, J. L., Newton, D. W., & Read, A. F. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.279 · Cited by 11 · see citing works
Antimicrobial tolerance and its role in the development of resistance: Lessons from enterococci
Darnell, R. L., Paxie, O., Rose, F. O. T., Morris, S. M., Krause, A. L., Monk, I. R., Smith, M. J. B., Stinear, T. P., Cook, G. M., & Gebhard, S. (2022) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2022.06.004 · Cited by 11 · see citing works
Mutant prevention concentrations of daptomycin for Enterococcus faecium clinical isolates
Sinel, C., Jaussaud, C., Auzou, M., Giárd, J.-C., & Cattoir, V. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.07.006 · Cited by 11 · see citing works
Menon, V., Davis, R. J., Shackel, N. A., Espedido, B. A., Beukers, A. G., Jensen, S. O., & van Hal, S. J. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.10.017 · Cited by 10 · see citing works
Rossolini, G. M., Arena, F., & Pollini, S. (2013) · Springer eBooks · doi:10.1007/978-3-642-39968-8_2 · Cited by 11 · see citing works
Godlewska, A., Pawlak, K., & Jańczewski, D. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103738 · Cited by 9 · see citing works
Tymoszewska, A., Szylińska, M., & Aleksandrzak‐Piekarczyk, T. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00343-23 · Cited by 9 · see citing works
Chow, A. L., Win, N.-N., Ng, P. Y., Lee, W., & Win, M.-K. (2016) · Epidemiology and Infection · doi:10.1017/s0950268816000923 · Cited by 8 · see citing works
Belley, A. C., Séguin, D. L., Arhin, F. F., & Moeck, G. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01265-17 · Cited by 8 · see citing works
Rincón, S., Panesso, D., Miller, W. R., Singh, K. V., Cruz, M. R., Khan, A., Dinh, A. Q., Díaz, L., Ríos, R., Shamoo, Y. E., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz131 · Cited by 8 · see citing works
Self-citationCard, K. J., Crozier, D., Durmaz, A., Gray, J., Creary, J., Stocks, A., Maltas, J., Bonomo, R. A., Burke, Z. D. C., & Scott, J. G. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2507962122 · Cited by 7 · see citing works
Enterococcal Infections and Drug Resistance Mechanisms
Sarathy, M. V., Balaji, S., & Rao, T. J. M. (2020) · Springer eBooks · doi:10.1007/978-981-15-1695-5_9 · Cited by 7 · see citing works
Pinto, L., Torres, C., Gil, C., Santos, H. M., Capelo, J. L., Borges, V., Gomes, J. P., Silva, C., Vieira, L., Poeta, P. A. C. Q. D., et al. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2019.0164 · Cited by 5 · see citing works
Cusumano, J. A., Daffinee, K. E., Piehl, E. C., Garcia-Solache, M. A., Desbonnet, C. R., Rice, L. B., & LaPlante, K. L. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00426-22 · Cited by 5 · see citing works
Mathpal, S., Panickar, A., Joshi, T., Ramaiah, S., & Anbarasu, A. (2025) · Current Genetics · doi:10.1007/s00294-025-01331-y · Cited by 4 · see citing works
Recent Epidemiological Changes in Infectious Diseases
Pucci, M. J., Callebaut, C., Cathcart, A. L., & Bush, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12405-9 · Cited by 4 · see citing works
Morley, V. J., Sim, D. G., Penkevich, A., Woods, R. J., & Read, A. F. (2022) · Evolution Medicine and Public Health · doi:10.1093/emph/eoac035 · Cited by 4 · see citing works
Nigo, M., Hasbun, R., & Vigil, K. J. (2018) · OBM Transplantation · doi:10.21926/obm.transplant.1804023 · Cited by 3 · see citing works
Paz, D. L., & Tattevin, P. (2026) · Critical Care · doi:10.1186/s13054-026-06011-y · Cited by 3 · see citing works
Development of VRE meningitis due to haematogenous spread while on high-dose daptomycin therapy
Sanikommu, S., Lusardi, K. T., Burdine, L. J., & Dare, R. K. (2023) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlad118 · Cited by 2 · see citing works
- Authors
- Munita, J. M., Panesso, D., Diaz, L., Tran, T. T., Reyes, J., Wanger, A., Murray, B. E., & Arias, C. A.
- Affiliations
- Universidad del Desarrollo (CL)
- Universidad El Bosque (CO)
- Laboratory for Antimicrobial Research, University of Texas Medical School at Houston, Houston, Texas, USA
- University of Houston (US)
- The University of Texas Health Science Center at Houston (US)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2012-08
- Volume
- 56
- Issue
- 8
- Pages
- 4354-4359
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3421602
- OpenAlex
- W2107978429
- Cited by
- 118
- References
- 37
- Citations by year
- 2026: 8 · 2025: 3 · 2023: 6 · 2022: 12 · 2021: 2 · 2020: 12 · 2019: 4 · 2018: 12 · 2017: 8 · 2016: 17 · 2015: 12 · 2014: 13 · 2013: 7 · 2012: 2
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Repositorio Institucional Universidad El Bosque (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI093749, R00AI072961, R01 AI72961, K99AI072961)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- daptomycin resistance, Enterococcus faecium, minimum inhibitory concentration, envelope stress response, bloodstream isolates, antimicrobial susceptibility testing
- MeSH terms
- Anti-Bacterial Agents, Bacterial Proteins, Base Sequence, Cell Wall, DNA, Bacterial, Microbial Sensitivity Tests, Mutation, Vancomycin, Enterococcus faecium, Sequence Analysis, DNA, Daptomycin, Vancomycin Resistance, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review